KCNH2 and cervical squamous cell carcinoma: KCNH2 was significantly differentially expressed in samples grouped by CNV type in 10 tumours (GBMLGG, LGG, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), BRCA, STES, SARC, KIRP, mesothelioma (MESO), PAAD, OV) (Fig. 5B).